Letters to the Editor
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary
G.L. Fonti1, M.S. Chimenti2, E. Greco3, L. Boffa4, P. Conigliaro5, P. Triggianese6, R. Perricone7
- Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy. glfonti@hotmail.it
- Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
- Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
- Department of Neurosciences, MS Centre, Tor Vergata University, Rome, Italy.
- Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
- Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
- Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
CER13370
2021 Vol.39, N°1
PI 0223
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 32452349 [PubMed]
Received: 27/03/2020
Accepted : 09/04/2020
In Press: 20/05/2020
Published: 05/02/2021
